0 évaluation0% ont trouvé ce document utile (0 vote)
89 vues5 pages
Lowering triglycerides and apolipoprotein b in a subject in need thereof. Comprising: administering to said subject about 4 g per day of a pharmaceutical composition comprising at least about 96%, by weight, ethyl eicosapentaenoate. The pharmaceutical composition is administered to the subject 1 to 4 times per day. The method of claim 1 wherein the subject is not on concomitant concurrent lipid-altering therapy comprises
Lowering triglycerides and apolipoprotein b in a subject in need thereof. Comprising: administering to said subject about 4 g per day of a pharmaceutical composition comprising at least about 96%, by weight, ethyl eicosapentaenoate. The pharmaceutical composition is administered to the subject 1 to 4 times per day. The method of claim 1 wherein the subject is not on concomitant concurrent lipid-altering therapy comprises
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme PDF, TXT ou lisez en ligne sur Scribd
Lowering triglycerides and apolipoprotein b in a subject in need thereof. Comprising: administering to said subject about 4 g per day of a pharmaceutical composition comprising at least about 96%, by weight, ethyl eicosapentaenoate. The pharmaceutical composition is administered to the subject 1 to 4 times per day. The method of claim 1 wherein the subject is not on concomitant concurrent lipid-altering therapy comprises
Droits d'auteur :
Attribution Non-Commercial (BY-NC)
Formats disponibles
Téléchargez comme PDF, TXT ou lisez en ligne sur Scribd